Shanmuganathan, N., Wadham, C., Shahrin, N., Feng, J., Thomson, D., Wang, P., Saunders, V., Kok, C. H., King, R. M., Kenyon, R. R., Lin, M., Pagani, I. S., Ross, D. M., Yong, A. S., Grigg, A. P., Mills, A. K., Schwarer, A. P., Braley, J., Altamura, H., Yeung, D. T., Scott, H. S., Schreiber, A. W., Hughes, T. P. and Branford, S. (2023) “Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention”, Haematologica. Pavia, Italy, 108(9), pp. 2380-2395. doi: 10.3324/haematol.2022.282184.